Robinhood, Applovin jump as S&P 500 reshuffle boosts index entrants
This article summarizes the most significant insider buys and sells reported for US stocks on Monday, June 30, 2025.
Top Insider Buys:
• Kymera Therapeutics, Inc. (NASDAQ:KYMR) saw substantial insider buying from Baker Bros. Advisors and related entities. The biotechnology company, valued at $2.89 billion, has shown strong momentum with a 41% return over the past year. The transactions involved the acquisition of 655,500 shares of common stock at $44.00 per share, totaling $28,842,000. Specifically, 667, L.P. acquired 55,191 shares, while Baker Brothers Life Sciences, L.P. purchased 600,309 shares.
• BridgeBio Pharma, Inc. (NASDAQ:BBIO), a biotechnology company with an $8.2 billion market cap, reported insider buying from Director Hannah Valantine. Valantine acquired a total of 2,338 shares in two separate transactions, with prices ranging from $12.68 to $13.16, for a total value of $30,027. The stock has demonstrated remarkable performance, delivering a 70% return over the past year and currently trading near its 52-week high of $45.48.
• LTC Properties INC (NYSE:LTC) saw insider buying from Executive Vice President and CIO David M. Boitano. The healthcare REIT, with a market capitalization of $1.59 billion and a 6.61% dividend yield, reported Boitano’s purchase of 10,000 shares in three separate transactions. The prices ranged from $34.5 to $34.8 per share, totaling an investment of $346,260. Following these transactions, Boitano directly owns 15,626 shares of LTC Properties.
• TILLY’S, INC. (NASDAQ:TLYS) reported significant insider buying from Shay Capital LLC, a ten-percent owner. The firm made multiple purchases totaling 232,578 shares, with prices ranging from $1.25 to $1.4656, resulting in a total investment of $318,269. These purchases occurred as TLYS shares have declined nearly 80% over the past year.
• Netsol Technologies Inc (NASDAQ:NTWK) CEO Najeeb Ghauri reported purchasing 4,950 shares of common stock at $3.11 per share, totaling $15,394. This insider purchase comes as the $36.42 million market cap company demonstrates strong momentum, with shares up 12.2% over the past six months.
Top Insider Sells:
• Argan INC (NASDAQ:NYSE:AGX) reported insider selling from two directors. Peter W. Getsinger sold 3,456 shares at $212.01 per share, totaling $732,706. Additionally, William F. Leimkuhler sold a total of 11,655 shares in two separate transactions, with prices ranging from $221.25 to $222.03 per share, for a total of approximately $2,584,599. The company, valued at $3 billion, trades near its 52-week high and has shown remarkable performance with a 212% return over the past year.
• Broadcom Inc. (NASDAQ:AVGO) President and CEO Tan Hock E sold 40,000 shares of the company’s common stock. The shares were sold at prices ranging from $268.22 to $268.61, with an average price of $268.293, for a total transaction value of $10,731,720. Following the transaction, Tan Hock E directly owns 482,836 shares and indirectly owns 974,152 shares through a trust.
• Dell Technologies Inc. (NASDAQ:NYSE:DELL) reported significant insider selling from Silver Lake, a major shareholder. The firm sold a large block of Class C Common Stock worth approximately $78.9 million, with shares sold at a weighted average price ranging from $125.98 to $126.34.
• The Kroger Co . (NYSE:KR) reported insider selling, with an executive directly owning 184,473 shares following the transaction. The company has demonstrated strong shareholder commitment, raising its dividend for 19 consecutive years and maintaining an active share buyback program.
Investors should stay tuned to insider buys and sells as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the basis for investment decisions, they can offer additional context when combined with fundamental and technical analysis. It’s important to consider the overall market conditions, company performance, and other relevant factors when interpreting insider activity.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.